Circulating HMGB1 and RAGE as Clinical Biomarkers in Malignant and Autoimmune Diseases
High molecular group box 1 (HMGB1) is a highly conserved member of the HMG-box-family; abundantly expressed in almost all human cells and released in apoptosis; necrosis or by activated immune cells. Once in the extracellular space, HMGB1 can act as a danger associated molecular pattern (DAMP), thus...
Main Authors: | Christin Pilzweger, Stefan Holdenrieder |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-06-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | http://www.mdpi.com/2075-4418/5/2/219 |
Similar Items
-
Assessment of EN-RAGE, sRAGE and EN-RAGE/sRAGE as potential biomarkers in patients with autoimmune hepatitis
by: Rui Wu, et al.
Published: (2020-10-01) -
Immunogenic Biomarkers HMGB1 and sRAGE Are Potential Diagnostic Tools for Ovarian Malignancies
by: Lars Schröder, et al.
Published: (2023-10-01) -
HMGB1/RAGE axis in tumor development: unraveling its significance
by: Anqi Fan, et al.
Published: (2024-03-01) -
Role of the Receptor for Advanced Glycation End Products (RAGE) and Its Ligands in Inflammatory Responses
by: Kaylen Cross, et al.
Published: (2024-12-01) -
Metabolic Syndrome and Autophagy: Focus on HMGB1 Protein
by: Vincenza Frisardi, et al.
Published: (2021-04-01)